Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 392

1.

Expression of prostate-specific membrane antigen in renal cortical tumors.

Al-Ahmadie HA, Olgac S, Gregor PD, Tickoo SK, Fine SW, Kondagunta GV, Scher HI, Morris MJ, Russo P, Motzer RJ, Reuter VE.

Mod Pathol. 2008 Jun;21(6):727-32. doi: 10.1038/modpathol.2008.42. Epub 2008 Mar 14.

2.

Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms.

Baccala A, Sercia L, Li J, Heston W, Zhou M.

Urology. 2007 Aug;70(2):385-90.

PMID:
17826525
3.

Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.

Kuehn A, Paner GP, Skinnider BF, Cohen C, Datta MW, Young AN, Srigley JR, Amin MB.

Am J Surg Pathol. 2007 Oct;31(10):1528-33.

PMID:
17895753
4.

Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.

Chang SS, Reuter VE, Heston WD, Bander NH, Grauer LS, Gaudin PB.

Cancer Res. 1999 Jul 1;59(13):3192-8.

5.

Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.

Osunkoya AO, Cohen C, Lawson D, Picken MM, Amin MB, Young AN.

Hum Pathol. 2009 Feb;40(2):206-10. doi: 10.1016/j.humpath.2008.07.002. Epub 2008 Sep 16.

PMID:
18799195
6.

Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen.

Chang SS, Reuter VE, Heston WD, Gaudin PB.

Urology. 2001 Apr;57(4):801-5.

PMID:
11306418
7.

Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases.

Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R.

Mod Pathol. 2004 Feb;17(2):180-8.

8.

Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes.

Renshaw AA, Granter SR, Fletcher JA, Kozakewich HP, Corless CL, Perez-Atayde AR.

Am J Surg Pathol. 1999 Jul;23(7):795-802.

PMID:
10403302
9.

Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.

Kauffman EC, Barocas DA, Chen YT, Yang XJ, Scherr DS, Tu JJ.

J Urol. 2009 May;181(5):2305-11. doi: 10.1016/j.juro.2009.01.003. Epub 2009 Mar 19.

PMID:
19303095
10.
11.

Different immunohistochemical patterns of Fhit protein expression in renal neoplasms.

Eyzaguirre EJ, Miettinen M, Norris BA, Gatalica Z.

Mod Pathol. 1999 Oct;12(10):979-83.

PMID:
10530564
12.

Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study.

Yakirevich E, Matoso A, Sabo E, Wang LJ, Tavares R, Meitner P, Morris DJ, Pareek G, Delellis RA, Resnick MB.

Hum Pathol. 2011 Nov;42(11):1684-92. doi: 10.1016/j.humpath.2011.01.014. Epub 2011 Apr 29.

PMID:
21531004
13.

Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas.

Fritzsche FR, Oelrich B, Johannsen M, Kristiansen I, Moch H, Jung K, Kristiansen G.

Clin Cancer Res. 2008 Nov 1;14(21):7035-42. doi: 10.1158/1078-0432.CCR-08-0855.

14.

C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.

Huo L, Sugimura J, Tretiakova MS, Patton KT, Gupta R, Popov B, Laskin WB, Yeldandi A, Teh BT, Yang XJ.

Hum Pathol. 2005 Mar;36(3):262-8.

PMID:
15791570
15.

Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence.

Gilcrease MZ, Guzman-Paz M, Niehans G, Cherwitz D, McCarthy JB, Albores-Saavedra J.

Cancer. 1999 Dec 1;86(11):2320-6.

PMID:
10590373
16.

Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases.

Cochand-Priollet B, Molinié V, Bougaran J, Bouvier R, Dauge-Geffroy MC, Deslignières S, Fournet JC, Gros P, Lesourd A, Saint-André JP, Toublanc M, Vieillefond A, Wassef M, Fontaine A, Groleau L.

Arch Pathol Lab Med. 1997 Oct;121(10):1081-6.

PMID:
9341588
17.

Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study.

Mazal PR, Stichenwirth M, Koller A, Blach S, Haitel A, Susani M.

Mod Pathol. 2005 Apr;18(4):535-40.

18.
19.

Parvalbumin is constantly expressed in chromophobe renal carcinoma.

Martignoni G, Pea M, Chilosi M, Brunelli M, Scarpa A, Colato C, Tardanico R, Zamboni G, Bonetti F.

Mod Pathol. 2001 Aug;14(8):760-7.

20.

Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer.

Ross JS, Sheehan CE, Fisher HA, Kaufman RP Jr, Kaur P, Gray K, Webb I, Gray GS, Mosher R, Kallakury BV.

Clin Cancer Res. 2003 Dec 15;9(17):6357-62.

Supplemental Content

Support Center